Renoprotective effects of erythropoietin

Pisut Katavetin; Somchai Eiam-Ong; Nangaku, Masaomi

dc.contributor.author	Pisut Katavetin
dc.contributor.author	Somchai Eiam-Ong
dc.contributor.author	Nangaku, Masaomi
dc.contributor.other	Chulalongkorn University. Faculty of Medicine
dc.contributor.other	Chulalongkorn University. Faculty of Medicine
dc.contributor.other	University of Tokyo. School of Medicine
dc.date.accessioned	2010-12-28T04:52:45Z
dc.date.available	2010-12-28T04:52:45Z
dc.date.issued	2007
dc.identifier.citation	Asian biomedicine : research, reviews and news. 1,2(August 2007) : 139-150	en
dc.identifier.issn	1905-7415
dc.identifier.uri	http://cuir.car.chula.ac.th/handle/123456789/14319
dc.description.abstract	To summarize evidences of the renoprotective effects of EPO and review the possible mechanisms of renoprotection provided by EPO. Results: Experimental studies have demonstrated the renoprotective effects of EPO in acute as well as chronic renal injury models. These renoprotective actions are likely to be mediated by several mechanisms, either directly or indirectly. However, EPO therapy is also associated with adverse effects. Conclusion: EPO is potentially a novel renoprotective drug. Clinical use of EPO for renoprotection could not be beneficial if adverse side effects of EPO have been overcome.	en
dc.format.extent	354044 bytes
dc.format.mimetype	application/pdf
dc.language.iso	en	es
dc.publisher	Chulalongkorn University	en
dc.rights	Chulalongkorn University	en
dc.subject	Kidneys -- Diseases	en
dc.subject	Erythropoietin	en
dc.title	Renoprotective effects of erythropoietin	en
dc.type	Article	es
dc.email.author	No information provided
dc.email.author	No information provided
dc.email.author	No information provided
dc.subject.keyword	Erythropoietin	en
dc.subject.keyword	Renoprotection	en
dc.subject.keyword	Kidney disease	en